Cerebrospinal fluid distribution of ketoprofen after intravenous administration in young children

Clinical Pharmacokinetics

Volumn 45, Issue 7, 2006, Pages 737-743

  Mannila, Anne ^a   Kokki, Hannu ^a,b   Heikkinen, Marja ^b   Laisalmi, Merja ^b   Lehtonen, Marko ^a   Louhisto, Hanna L ^a   Järvinen, Tomi ^a   Savolainen, Jouko ^a  

^a UNIVERSITY OF EASTERN FINLAND   (Finland)

^b KUOPIO UNIVERSITY HOSPITAL   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

KETOPROFEN; NONSTEROID ANTIINFLAMMATORY AGENT; PLASMA PROTEIN;

ARTICLE; CEREBROSPINAL FLUID; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG BLOOD LEVEL; DRUG DISTRIBUTION; FEMALE; GAS CHROMATOGRAPHY; HUMAN; MALE; MASS SPECTROMETRY; PRIORITY JOURNAL; SPINAL ANESTHESIA; VENOUS BLOOD;

ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; BLOOD PROTEINS; CHILD; CHILD, PRESCHOOL; FEMALE; GAS CHROMATOGRAPHY-MASS SPECTROMETRY; HUMANS; INFANT; INFUSIONS, INTRAVENOUS; KETOPROFEN; MALE; PROSPECTIVE STUDIES; PROTEIN BINDING;

EID: 33745700167     PISSN: 03125963     EISSN: 03125963     Source Type: Journal    
DOI: 10.2165/00003088-200645070-00008     Document Type: Article

References (19)

1. Herrero JF, Parrado A, Cervero F. Central and peripheral actions of the NSAID ketoprofen on spinal cord nociceptive reflexes. Neuropharmacology 1997; 36: 1425-31
2. Ossipov MH, Jerussi TP, Ren K, et al. Differential effects of spinal (R)-ketoprofen and (S)-ketoprofen against signs of neuropathic pain and tonic nociception: evidence for a novel mechanism of action of (R)-ketoprofen against tactile allodynia. Pain 2000; 87: 193-9
3. Austin RP, Barton P, Cockroft SL, et al. The influence of nonspecific microsomal binding on apparent intrinsic clearance, and its prediction from physicochemical properties. Drug Metab Dispos 2002; 30: 1497-503
4. Herrador MÁ, González AG. Potentiometric titrations in acetonitrile-water mixtures: evaluation of aqueous ionisation constant of ketoprofen. Talanta 2002; 56: 769-75
5. Abbott NJ. Evidence for bulk flow of brain interstitial fluid: significance for physiology and pathology. Neurochem Int 2004; 45: 545-52
6. Netter P, Lapicque F, Bannwarth B, et al. Diffusion of intramuscular ketoprofen into the cerebrospinal fluid. Eur J Clin Pharmacol 1985; 29: 319-21
7. Kokki H, Karvinen M, Jekunen A. Diffusion of ketoprofen into the cerebrospinal fluid of young children. Paediatr Anaesth 2002; 12: 313-6
8. Kokki H. Nonsteroidal anti-inflammatory drugs for postoperative pain: a focus on children. Paediatr Drugs 2003; 5: 103-23
9. Leis HJ, Leis M, Windischhofer W. Stable isotope labelling and determination of ketroprofen in human plasma and urine by gas chromatography/negative ion chemical ionization mass spectrometry. J Mass Spectrom 1996; 31: 486-92
10. Guidance for Industry, Bioanalytical Method Validation. US Department of Health and Human Services, Food and Drug Administration, Center for Drug Evaluation and Research (CDER), Center for Veterinary Medicine (CVM), 2001 May [online]. Available from URL: http://www.fda.gov/cder/guidance/4252fnl.pdf [Accessed 2006 May 18]
11. Sheiner LB. The population approach to pharmacokinetic data analysis: rationale and standard data analysis methods. Drug Metab Rev 1984; 15: 153-71
12. Fowler PD, Dawes PT. Osmosin: its effect on plasma and synovial fluid kinetics of indomethacin. Eur J Clin Pharmacol 1985; 27: 689-91
13. Nau R, Zysk G, Thiel A, et al. Pharmacokinetic quantification of the exchange of drugs between blood and cerebrospinal fluid in man. Eur J Clin Pharmacol 1993; 45: 469-75
14. Mazario J, Roza C, Herrero JF. The NSAID dexketoprofen trometamol is as potent as mu-opioids in the depression of wind-up and spinal cord nociceptive reflexes in normal rats. Brain Res 1999; 816: 512-7
15. Rowland M, Tozer TN. Clinical pharmacokinetics, consepts and applications. 3rd ed. Philadelphia (PA): Lippincott Williams & Wilkins, 1995
16. Davson H, Segal MB. Physiology of the CSF and the blood-brain barriers. New York: CRC Press Inc., 1996
17. Deguchi Y, Hayashi H, Fujii S, et al. Improved brain delivery of a nonsteroidal anti-inflammatory drug with a synthetic glyceride ester: a preliminary attempt at a CNS drug delivery system for the therapy of Alzheimer's disease. J Drug Target 2000; 8: 371-81
18. Ohtsuki S, Asaba H, Takanaga H, et al. Role of blood-brain barrier organic anion transporter 3 (OAT3) in the efflux of indoxyl sulfate, a uremic toxin: its involvement in neurotransmitter metabolite clearance from the brain. J Neurochem 2002; 83: 57-66
19. Ohtsuki S. New aspects of the blood-brain barrier transporters; its physiological roles in the central nervous system. Biol Pharm Bull 2004; 27: 1489-96